zalcitabine has been researched along with Adenoviridae Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, YJ; Romanowski, EG | 1 |
| Gordon, YJ; Romanowski, EG; Yates, KA | 1 |
| Mentel, R; Wegner, U | 1 |
3 other study(ies) available for zalcitabine and Adenoviridae Infections
| Article | Year |
|---|---|
Update on antiviral treatment of adenoviral ocular infections.
Topics: Adenoviridae Infections; Animals; Antiviral Agents; Cytidine; Eye Infections; Humans; Immunoglobulins, Intravenous; Zalcitabine | 2008 |
The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections.
Topics: Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Conjunctivitis, Viral; Cytosine; Disease Models, Animal; Female; Humans; Organophosphonates; Rabbits; Tumor Cells, Cultured; Viral Plaque Assay; Virus Replication; Zalcitabine | 2009 |
Evaluation of the efficacy of 2',3'-dideoxycytidine against adenovirus infection in a mouse pneumonia model.
Topics: Adenoviridae Infections; Administration, Oral; Animals; DNA, Viral; Female; Lung; Mastadenovirus; Mice; Mice, Inbred BALB C; Pneumonia, Viral; Polymerase Chain Reaction; Treatment Outcome; Tumor Necrosis Factor-alpha; Zalcitabine | 2000 |